Right ventricular myocardial infarction: Difference between revisions
No edit summary |
|||
| Line 24: | Line 24: | ||
[[ST Elevation Myocardial Infarction: Pathophysiology of Reperfusion|Pathophysiology of Reperfusion]] | [[ST elevation myocardial infarction gross pathology|Gross Pathology]] | [[ST elevation myocardial infarction histopathology|Histopathology]] | [[ST Elevation Myocardial Infarction: Pathophysiology of Reperfusion|Pathophysiology of Reperfusion]] | [[ST elevation myocardial infarction gross pathology|Gross Pathology]] | [[ST elevation myocardial infarction histopathology|Histopathology]] | ||
==[[Right ventricular myocardial infarction causes|Causes | ==[[Right ventricular myocardial infarction causes|Causes]]== | ||
==[[Right ventricular myocardial infarction differential diagnosis|Differentiating Right ventricular myocardial infarction from other Diseases]]== | ==[[Right ventricular myocardial infarction differential diagnosis|Differentiating Right ventricular myocardial infarction from other Diseases]]== | ||
== [[ST elevation myocardial infarction epidemiology and demographics|Epidemiology and Demographics]] == | == [[ST elevation myocardial infarction epidemiology and demographics|Epidemiology and Demographics]] == | ||
Revision as of 14:14, 20 September 2012
| Myocardial infarction | |
| ICD-10 | I21-I22 |
|---|---|
| ICD-9 | 410 |
| DiseasesDB | 8664 |
| MedlinePlus | 000195 |
| MeSH | D009203 |
|
Right ventricular myocardial infarction Microchapters |
|
Differentiating Right ventricular myocardial infarction from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Pharmacological Reperfusion |
|
Mechanical Reperfusion |
|
Antithrombin Therapy |
|
Antiplatelet Agents |
|
Other Initial Therapy |
|
Right ventricular myocardial infarction On the Web |
|
Directions to Hospitals Treating Right ventricular myocardial infarction |
|
Risk calculators and risk factors for Right ventricular myocardial infarction |
For patient information click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]; Priyamvada Singh, M.D. [3]
Overview
Pathophysiology
Pathophysiology of Reperfusion | Gross Pathology | Histopathology
Causes
Differentiating Right ventricular myocardial infarction from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications & Prognosis
Diagnosis
Diagnostic Criteria | History & Symptoms | Physical Examination | Electrocardiogram | Chest X Ray | Echocardiography or Ultrasound | Coronary Angiography
Treatment
Pharmacologic Reperfusion | Reperfusion Therapy (Overview of Fibrinolysis and Primary PCI) | Fibrinolysis
Mechanical Reperfusion | The importance of reducing Door-to-Balloon times | Primary PCI | Adjunctive and Rescue PCI | Rescue PCI | Facilitated PCI | Adjunctive PCI | CABG | Management of Patients Who Were Not Reperfused | Assessing Success of Reperfusion
Antithrombin Therapy • Antithrombin therapy • Unfractionated heparin • Low Molecular Weight Heparinoid Therapy • Direct Thrombin Inhibitor Therapy • Factor Xa Inhibition • DVT prophylaxis • Long term anticoagulation
Antiplatelet Agents | Aspirin | Thienopyridine Therapy | Glycoprotein IIbIIIa Inhibition
Other Initial Therapy | Inhibition of the Renin-Angiotensin-Aldosterone System | Magnesium Therapy | Glucose Control | Calcium Channel Blocker Therapy